Adverum Biotechnologies Inc (NAS:ADVM)
$ 7.31 -0.19 (-2.53%) Market Cap: 151.73 Mil Enterprise Value: 36.83 Mil PE Ratio: 0 PB Ratio: 0.83 GF Score: 38/100
Back to the Transcripts List

Adverum Biotechnologies Inc at Goldman Sachs Global Healthcare Conference (Virtual) Transcript

Jun 11, 2020 / 07:50PM GMT
Release Date Price: $213.2 (-10.68%)
Graig Suvannavejh
Goldman Sachs Group Inc., Research Division - Executive Director & Senior Equity Research Analyst

Okay, thank you, everyone, and welcome to 3:50 p.m. session on Day 3 of the Goldman Sachs Global Healthcare Conference. My name is Graig Suvannavejh. I'm a senior analyst covering European and U.S. biopharma for the firm. It's my great pleasure to be hosting Adverum today for our fireside chat. We'll have about 40 minutes to get to know the company and ask questions, and I've got the pleasure of introducing 3 members of the senior management team, CEO, Leone Patterson; Chief Medical Officer, Aaron Osborne; and Chief Financial Officer, Thomas Leung.

So as we go into our fireside chat, let me first welcome Adverum to our conference. Hopefully, we can do this in-person next year out in, hopefully, sunny Southern California and sort of look forward to your participation in years to come.

For the audience, for those of you who may not know the Adverum story, maybe we can start by asking the management team and maybe, Leone, I'll pass it over to you, by just giving us kind

Already have an account? Log in
Get the full story
Start 7-Day Free Trial
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot
Research Tools
All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board
Product
Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文
Education
Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation
Company
About GuruFocus Career Contact Us ETF Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program
Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey
Follow Us
download GuruFocus on Apple store download GuruFocus on Google Play
Disclaimers
GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.
© 2004-2024 GuruFocus.com, LLC. All Rights Reserved.